EID Parry Q4 FY26 Results Analysis: PAT Swings to Loss, Crop Protection Surges 54%

CompoundingAI Research Updated May 26, 2026 2 min read
Negative

EID Parry (India) Ltd's Q4 FY26 numbers came in soft. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateMay 26, 2026
QuarterQ4 FY 2025-2026
Revenue (Q4)Rs. 7,882.33 Cr (+15.70% YoY)
PAT (Q4)Rs. -287.17 Cr
EBITDA margin8.40% (-80 bps YoY)
EPS (Q4)Rs. -18.74
Market capRs. 13,899.54 Cr
CMPRs. 780.95

Quarter Snapshot

EID Parry's Q4 FY26 results were severely impacted by Rs.478 Cr exceptional charges from the PSRIPL closure, swinging consolidated PAT to a loss. However, the underlying business showed stability with normalized PAT flat YoY, a sugar segment turnaround to full-year profit, and strong 54% growth in crop protection from the NACL acquisition. Input cost pressure, distillery margin collapse, and consumer products losses remain structural challenges.

Key Investment Insights

Key Positives

  • Revenue grew 15.7% YoY in Q4 and 21.9% for full year FY26, driven by crop protection (+54.1%) and nutrient (+14.6%) segments
  • Crop protection segment revenue increased 54.1% YoY on NACL acquisition, with segment margin of 11.2%
  • Sugar segment swung to profit: Rs.70 Cr in Q4 (vs Rs.3 Cr last year) and full-year profit of Rs.54 Cr vs loss Rs.115 Cr in FY25
  • EBITDA margin for FY26 improved to 9.9% from 9.5% in FY25
  • Normalized PAT (ex-exceptionals) was flat YoY at Rs.883 Cr, indicating underlying earnings stability
  • Cash and cash equivalents surged 203% YoY to Rs.1,222 Cr

Risk Factors

  • Consolidated PAT swung to loss of Rs.287 Cr in Q4 vs profit Rs.539 Cr last year due to Rs.478 Cr exceptional items from PSRIPL closure
  • Cost of materials consumed grew 30% YoY, outpacing revenue growth of 15.7%, indicating input cost pressure
  • Distillery segment profit collapsed 91% YoY to Rs.2 Cr due to flat ethanol pricing and cost pressures
  • Consumer products revenue declined 41% YoY and losses widened 2.6x to Rs.33 Cr in Q4
  • Standalone net worth declined 26% YoY due to PSRIPL closure-related exceptional losses
  • Free cash flow turned negative at Rs.76 Cr (FY26) vs positive Rs.890 Cr (FY25) due to elevated capex and acquisition costs
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now